Regulatory Information:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an progressive firm that designs, develops, and markets disposable medical gadgets supposed to safe the location of implants within the skeleton, introduced at this time its schedule for the publication of monetary info for 2021.
|
Occasion |
Date* |
|
2020 Full-12 months Gross sales |
January 27, 2021 |
|
2020 Full-12 months Outcomes |
April 8, 2021 |
|
2021 First-Quarter Gross sales |
April 15, 2021 |
|
Annual Shareholders Assembly |
June 9, 2021 |
|
2021 First-Half Gross sales |
July 7, 2021 |
|
2021 First-Half Outcomes |
September 15, 2021 |
|
2021 Third-Quarter Gross sales |
October 14, 2021 |
Word (*): Press releases are printed after inventory market closes. This info is topic to modification.
About SpineGuard®
Based in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an progressive firm deploying its proprietary radiation-free actual time sensing expertise DSG® (Dynamic Surgical Steerage) to safe and streamline the location of implants within the skeleton. SpineGuard designs, develops and markets medical gadgets which have been utilized in over 80,000 surgical procedures worldwide. Sixteen research printed in peer-reviewed scientific journals have demonstrated the a number of advantages DSG® gives to sufferers, surgeons, surgical workers and hospitals. Constructing on these stable fundamentals and a number of other strategic partnerships, SpineGuard has expanded its expertise platform in a disruptive innovation: the « good » pedicle screw launched late 2017 and is broadening the scope of purposes in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer.
For additional info, go to www.spineguard.com
Disclaimer
The SpineGuard securities might not be provided or offered in america as they haven’t been and won’t be registered beneath the Securities Act or any United States state securities legal guidelines, and SpineGuard doesn’t intend to make a public provide of its securities in america. That is an announcement and never a prospectus, and the data contained herein does and shall not represent a proposal to promote or the solicitation of a proposal to purchase, nor shall there be any sale of the securities referred to herein in america wherein such provide, solicitation or sale could be illegal previous to registration or exemption from registration.
View supply model on businesswire.com: https://www.businesswire.com/news/home/20210104005513/en/
Contacts
SpineGuard
Pierre Jérôme
President & CEO
Tel.: 01 45 18 45 19
p.jerome@spineguard.com
Manuel Lanfossi
CFO
m.lanfossi@spineguard.com
Europe / NewCap
Investor Relations & Monetary Communication
Mathilde Bohin / Pierre Laurent
Tél. : 01 44 71 94 94
spineguard@newcap.eu
